Characterization of molecular interactions between intercellular adhesion molecule-1 and leukocyte function-associated antigen-1

Journal of Immunology

Volumn 156, Issue 12, 1996, Pages 4680-4685

  Woska Jr , Joseph R ^a   Morelock, Maurice M ^a   Jeanfavre, Deborah Durham ^a   Bormann, Barbara Jean ^a  

^a BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

ANTIGEN PRESENTATION; ARTICLE; BINDING COMPETITION; CELL ADHESION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIGAND BINDING; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY;

BINDING, COMPETITIVE; BIOTIN; CELL-FREE SYSTEM; INTERCELLULAR ADHESION MOLECULE-1; KINETICS; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; PROTEIN BINDING; RECOMBINANT PROTEINS; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029882940     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
2. Kishimoto, T. K., and R. Rothlein. 1994. Integrins, ICAMs, and selectins: role and regulation of adhesion molecules in neutrophil recruitment to inflammatory sites. Adv. Pharmacol. 25:117.
3. Rothlein, R., and L. A. Scharschmidt. 1994. Leukocyte adhesion in inflammation: from discovery to the clinic. In Adhesion Molecules. C. D. Wegner, ed. Academic Press Limited, New York, p. 1.
4. Cosimi, A. B., D. Conti, F. L. Delmonico, F. I. Preffer, S. L. Wee, R. Rothlein, R. Faanes, and R. B. Colvin. 1990. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144: 4604.
5. Kavanaugh, A. F., L. S. Davis, L. A. Nichols, S. H. Norris, R. Rothlein, L. A. Scharschmidt, and P. E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule I. Arthritis Rheum. 37:992.
6. Haug, C. E., R. B. Colvin, F. L. Delmonico, H. J. Auchincloss, N. Tolkoff-Rubin, F. I. Preffer, R. Rothlein, S. Norris, L. Scharschmidt, and A. B. Cosimi. 1993. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766.
7. Marlin, S. D., D. E. Stauton, T. A. Springer, C. Stratowa, W. Sommergruber, and V. J. Merluzzi. 1990. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 344:70.
8. Arruda, E., C. E. Crump, S. D. Marlin, V. J. Merluzzi, and F. G. Hayden. 1992. In vitro studies of the antirhinovirus activity of soluble intercellular adhesion molecule-1. Antimicrob. Agents Chemother. 36:1186.
9. Greve, J. M., G. Davis, A. M. Meyer, C. P. Forte, S. C. Yost, C. W. Marlor, M. E. Kamarck, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839.
10. Staunton, D. E., C. F. Ockenhouse, and T. A. Springer. 1992. Soluble intercellular adhesion molecule 1-immunoglobulin G1 immunoadhesion mediates phagocytosis of malaria-infected erythrocytes. J. Exp. Med. 176:1471.
11. Becker, J. C., C. Termeer, R. E. Schmidt, and E.-B. Brocker. 1993. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J. Immunol. 151:7224.
12. Roep, B. O., E. Heidenthal, R. R. P. de Vries, H. Kolb, and S. Martin. 1994. Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 343:1590.
13. Rieckmann, P., U. Michel, M. Albrecht, W. Bruck, L. Wockel, and K. Felgenhauer. 1995. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60:9.
14. Welder, C. A., D. H. S. Lee, and F. Takei. 1993. Inhibition of cell adhesion by microspheres coated with recombinant soluble intercellular adhesion molecule-1. J. Immunol. 150(Suppl. 6):2203.
15. Meyer, D. M., M. L. Dustin, and C. P. Carron. 1995. Characterization of intercellular adhesion molecule-1 ectodomain (sICAM-1) as an inhibitor of lymphocyte function-associated molecule-1 interaction with ICAM-1. J. Immunol. 155: 3578.
16. Rothlein, R., E. A. Mainolfi, M. Czajkowski, and S. D. Marlin. 1991. A form of circulating ICAM-1 in human serum. J. Immunol. 147:3788.
17. Seth, R., F. D. Raymond, and M. W. Makgoba. 1991. Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders. Lancet 338: 83.
18. Smith, C. W., R. Rothlein, B. J. Hughes, M. M. Mariscalco, F. C. Schmalstieg, and D. C. Anderson. 1988. Recognition of an endothelial determinant for CD18-dependent neutrophil adherence and transendothelial migration. J. Clin. Invest. 82:1746.
19. Sanchez-Madrid, F., J. Nagy, E. Robbins, P. Simon, and T. A. Springer. 1983. A human leukocyte differentiation antigen family with distinct alpha subunits and a common beta subunit; lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. J. Exp. Med. 158:1785.
20. Staunton, D. E., M. L. Dustin, H. P. Erikson, and T. A. Springer. 1990. The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1 and rhinovirus. Cell 61:243.
21. Diamond, M. S., D. E. Staunton, S. D. Marlin, and T. A. Springer. 1991. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and ils regulation by glycosylation. Cell 65:961.
22. O'Shannessy, D. J., M. J. Doberson, and R. H. Quarks. 1984. A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties. Immunol. Lett. 8:273.
23. Dustin, M. L., O. Carpen, and T. A. Springer. 1992. Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. J. Immunol. 148:2654.
24. Nygren, H., and M. Stenberg. 1989. Immunochemistry at interfaces. Immunology 66:321.
25. Muller, B., H. G. Zerwes, K. Tangemann, J. Peter, and J. Engel. 1993. Two-step binding mechanism of fibrinogen to alpha IIb beta 3 integrin reconstituted into planar lipid bilayers. J. Biol. Chem. 268(Suppl. 9):6800.
26. Orlando, R. A., and D. A. Cheresh. 1991. Arginine-glycine-aspartic acid binding leading to molecular stabilization between integrin alpha V beta 3 and its ligand. J. Biol. Chem. 266(Suppl. 29):19543.
27. Miller, J., R. Knorr, M. Ferrone, R. Houdei, C. P. Carron, and M. L. Dustin. 1995. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J. Exp. Med. 182:1231.
28. Morelock, M. M., R. Rothlein, S. M. Bright, M. K. Robinson, E. T. Graham, J. P. Sabo, R. Owens, D. J. King, S. H. Norris, D. S. Scher, J. L. Wright, and J. R. Adair. 1994. Isotype choice for chimeric antibodies affects binding properties. J. Biol. Chem. 269:13048.
29. Mason, D. W., and A. F. Williams. 1986. Handbook of Experimental Immunology. Blackwell Scientific Publications, Oxford.
30. Reilly, P. L., J. R. Woska, Jr., D. D. Jeanfavre, E. McNally, R. Rothlein, and B. J. Bormann. 1995. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer: correlation with binding to LFA-1. J. Immunol. 155:529.
31. Hogg, N., C. Cabanas, and I. Dransfield. 1993. Leukocyte integrin activation. In Structure, Function, and Regulation of Molecules Involved in Leukocyte Adhesion. P. E. Lipsky, R. Rothlein, T. K. Kishimoto, R. B. Faanes, and C. W. Smith, eds. Springer-Verlag, New York, p. 3.
32. Figdor, C. G., and Y. van Kooyk. 1993. Activation of LFA-1: role of cations. In Structure, Function and Regulation of Molecules Involved in Leukocyte Adhesion. P. E. Lipsky, R. Rothlein, T. K. Kishimoto, R. B. Faanes, and C. W. Smith, eds. Springer-Verlag, New York, p. 14.
33. Hogg, N., J. Harvey, and C. Cabanas. 1993. Control of leukocyte integrin activation. Am. Rev. Respir. Dis. 148.-S55.
34. 2+ levels in the regulation of CD11a/CD18 mediated cell adhesion. Cell Adhes. & Comm. 1:21.
35. Lollo, B. A., K. W. H. Chan, E. M. Hanson, V. T. Moy, and A. A. Brian. 1993. Direct evidence for two affinity states for lymphocyte function-associated antigen 1 on activated T cells. J. Biol. Chem. 268:21693.
36. Hautanen, A., J. Gailit, D. M. Mann, and E. Ruoslahti. 1989. Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor. J. Biol. Chem. 264:1437.
37. Danilov, Y. N., and R. L. Juliano. 1989. Phorbol ester modulation of integrin-mediated cell adhesion: a postreceptor event. J. Cell Biol. 108:1925.
38. Akiyama, S. K., and K. M. Yamada. 1985. The interaction of plasma fibronectin with fibroblastic cells in suspension. J. Biol. Chem. 260:4492.
39. Chammas, R., S. S. Veiga, S. Line, P. Potocnjak, and R. R. Brentani. 1991. Asn-linked oligosaccharide-dependent interaction between laminin and gp120/ 140: an alpha 6/beta 1 integrin. J. Biol. Chem. 266:3349.
40. Martin, S., J. M. Cassanovas, D. E. Staunton, and T. A. Springer. 1993. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules. J. Virol. 67:3561.
41. Crump, C. E., E. Arruda, and F. G. Hayden. 1994. Comparative antirhinoviral activities of soluble intercellular adhesion molecule-1 (sICAM-1) and chimeric ICAM-1/immunoglobulin A molecule. Antimicroh. Agents Chemother. 38:1425.